Function Research and Regulatory Application Prospects of Leukemia Inhibitory Factor in Reproductive Biology

I. Biological Characteristics and Signal Transduction of LIF

Leukemia inhibitory factor (LIF) is a multifunctional secreted glycoprotein named for its ability to induce differentiation and inhibit proliferation of myeloid leukemia cells. It initiates the classical JAK-STAT3 signaling pathway by binding to a heterodimeric receptor complex composed of the LIF receptor β subunit and gp130 protein, thereby regulating the expression of downstream target genes. This signaling pathway is widely present in various reproductive-related cells including endometrial epithelial cells, oocytes, and trophoblasts, serving as the molecular basis for LIF's diverse reproductive regulatory functions.

II. The Central Role of LIF in Establishing Endometrial Receptivity

Successful embryo implantation depends on the receptive state of the endometrium during a specific period, known as the "implantation window." Studies show that LIF plays an indispensable role in this process. Its expression in endometrial luminal and glandular epithelium exhibits cyclical changes, peaking during the mid-to-late secretory phase, which coincides with the opening of the implantation window and the development of pinopodes. Functional studies confirm that LIF knockout mice exhibit normal embryo development but fail to implant, while their endometrium can regain receptivity upon exogenous LIF supplementation. The mechanism involves regulating the expression of epithelial junction proteins (e.g., E-cadherin) via STAT3 signaling to maintain epithelial integrity and promote embryo adhesion. Clinical observations also reveal significantly reduced LIF expression during the implantation window in some patients with unexplained infertility, suggesting that abnormal LIF expression may be associated with implantation failure.

III. LIF's Regulation of Follicular Development and Embryo Quality

The follicular microenvironment is crucial for oocyte maturation and early embryo development. As a key component of this microenvironment, LIF positively influences germ cell development. In vitro studies demonstrate that adding LIF to culture systems promotes the transition of primordial follicles to primary follicles and improves nuclear maturation rates of oocytes. For early embryos, LIF supplementation enhances blastocyst formation rates, hatching rates, and cell numbers, indicating its beneficial effects on in vitro developmental potential. Clinical data further show that LIF concentrations in follicular fluid during ovarian stimulation cycles correlate positively with oocyte maturity, fertilization rates, and high-quality embryo rates, suggesting LIF levels may serve as a potential biomarker for assessing follicular quality and embryo developmental potential.

IV. LIF's Role in Trophoblast Function and Tubal Factor Infertility

After embryo implantation, moderate trophoblast invasion is essential for placental formation. LIF promotes trophoblast proliferation, migration, and invasion by activating signaling pathways such as STAT3 and ERK1/2, while regulating the expression of extracellular matrix-related proteins to facilitate deep embryo implantation. Additionally, in tubal factor infertility (e.g., hydrosalpinx), studies reveal significantly downregulated LIF expression in the endometrium during the implantation window, which may contribute to impaired endometrial receptivity and reduced implantation rates. Surgical treatment of hydrosalpinx can restore endometrial LIF expression in some patients, indirectly confirming its role in maintaining a normal implantation environment.

V. Application Value of LIF His Tag Protein as a Research Tool

In-depth mechanistic studies of LIF's functions require highly pure, standardized recombinant LIF proteins as key tools. LIF His Tag protein, with its C- or N-terminal polyhistidine tag, enables efficient purification via metal chelate chromatography, ensuring high activity and low endotoxin levels. This tool protein can be widely applied in:

1. In vitro functional studies: Stimulating endometrial cells, cumulus-oocyte complexes, or trophoblast cell lines to directly investigate LIF's effects on cell proliferation, differentiation, gene expression, and signaling pathway activation (e.g., STAT3 phosphorylation).

2. Receptor binding and signal validation: Verifying its binding characteristics with LIFR/gp130 receptors and evaluating the blocking effects of specific inhibitors or antibodies on signaling pathways.

3. Animal model supplementation experiments: Serving as an exogenous supplement for intrauterine injections in LIF-deficient animal models to validate its functions in vivo.

4. Culture system optimization: Acting as a defined additive in optimizing embryo in vitro culture systems for assisted reproductive technologies to assess its specific improvements in embryo development quality.

VI. Summary and Future Perspectives

LIF is a key cytokine regulating the entire embryo implantation process—from follicular development and endometrial receptivity establishment to early embryo development and trophoblast invasion. A deeper understanding of its mechanisms not only advances fundamental reproductive biology but also provides potential intervention targets for improving assisted reproductive technology success rates. Future research should further elucidate changes in LIF signaling networks under various pathophysiological conditions (e.g., polycystic ovary syndrome, diminished ovarian reserve) and explore translational applications based on tools like LIF His Tag protein to develop strategies for enhancing endometrial receptivity or embryo quality, paving new avenues for precision diagnosis and treatment of infertility.